Sickle Cell disease

January 29, 2019January 29, 2019

Registration Open for Sickle Cell Foundation of Georgia’s Annual Camp New Hope

News

The Sickle Cell Foundation of Georgia (SCFG) will host its 42nd Annual Camp New Hope July 14-20 for youngsters living with sickle cell disease (SCD). The fun and enrichment ... Read more

August 7, 2018August 7, 2018

Approval of Sickle Cell Disease Bill by Senate Committee Welcomed by Emmaus Life Sciences

News

A U.S. Senate committee unanimously supported the Sickle Cell Disease Act of 2018, and Emmaus Life Sciences is also announcing its support of the bill. The Sickle Cell Disease Research, Surveillance, Prevention ... Read more

July 31, 2018July 31, 2018

HRI Protein Identified as Possible New Therapeutic Target for SCD, Study Shows

News

The HRI signaling protein was identified as a key negative regulator of hemoglobin production in red blood cells, unraveling a potential new therapeutic target for sickle cell disease (SCD). ... Read more

July 19, 2018July 19, 2018

White Blood Cells Regulate Levels of Fetal Hemoglobin in Sickle Cell Patients, Study Shows

News

White blood cells were seen to produce molecules that decrease a specific type of hemoglobin — the protein in red blood cells that’s responsible for the transport of oxygen — in ... Read more

June 13, 2018June 14, 2018

Potential Treatment Targeting Nitric Oxide Levels, Olinciguat, Named Orphan Drug by FDA

News

The U.S. Food and Drug Administration (FDA) recently granted orphan drug status to olinciguat (IW-1701) as a potential treatment of sickle cell disease (SCD), Ironwood Pharmaceuticals announced. Evidence suggests that the ... Read more

June 7, 2018June 7, 2018

Potential Sickle Cell Treatment Altemia Shows Promise in Phase 2 Trial, Data Reports

News

Sancilio Pharmaceuticals is reporting that its investigational oral compound Altemia (SC411, docosahexaenoic acid) showed an ability to safely treat sickle cell disease (SCD) in a Phase 2 study. Data from the Phase 2 ... Read more

March 6, 2018

Phase 1 Clinical Trial for Novel Sickle Cell Transplant Procedure Receives $5.74 Million

News

An upcoming Phase 1 clinical trial was recently awarded $5.74 million to evaluate an innovative blood stem cell transplant procedure for adults with severe sickle cell disease (SCD). The California ... Read more

January 23, 2018

Entrepreneur to Design New Voice-recognition Mobile App for Monitoring Blood Disease

News

England’s National Health Service (NHS) has selected 138 entrepreneurs to design and deliver new technological solutions for healthcare challenges – one of which was appointed to tackle conditions like ... Read more

October 31, 2017

Georgia Universities Join NIH-funded National Study of Bone Marrow Transplant for SCD

News

The Medical College of Georgia (MCG) and Augusta University Health (AU Health) have joined the first large, national clinical trial investigating bone marrow transplantation as part of the standard ... Read more

March 16, 2017March 16, 2017

Older Blood Used in Transfusions May Be Harmful to Adult Sickle Cell Patients, Review Finds

News

In an analysis of adults with sickle cell disease, researchers found evidence that transfusions with stored units of older blood were associated with higher rates of hospital admission due ... Read more

Pin It on Pinterest